Lazaratos, A., Dankner, M., Hamouda, A., Labidi, S., Cohen, V., Panasci, L., . . . Fallah, P. The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre. MDPI AG.
Chicago Style (17th ed.) CitationLazaratos, Anna-Maria, et al. The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre. MDPI AG.
MLA (9th ed.) CitationLazaratos, Anna-Maria, et al. The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre. MDPI AG.
Warning: These citations may not always be 100% accurate.